Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Consultas o comentarios: productividad@anid.cl
Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma
| Indexado |
|
||||
| DOI | 10.1158/1078-0432.CCR-18-2661 | ||||
| Año | 2019 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Abstract
Conclusions: These data support a "first in RDEB" phase II clinical trial of rigosertib to assess tumor targeting in patients with late stage, metastatic, and/or unresectable SCC.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Atanasova, Velina S. | Mujer |
Thomas Jefferson Univ - Estados Unidos
Thomas Jefferson University - Estados Unidos Sidney Kimmel Medical College - Estados Unidos |
| 2 | Pourreyron, Celine | - |
Univ Dundee - Reino Unido
University of Dundee - Reino Unido University of Dundee School of Medicine - Reino Unido |
| 3 | Farshchian, Mehdi | Hombre |
Thomas Jefferson Univ - Estados Unidos
Thomas Jefferson University - Estados Unidos Sidney Kimmel Medical College - Estados Unidos |
| 4 | Lawler, Michael | Hombre |
Thomas Jefferson Univ - Estados Unidos
Thomas Jefferson University - Estados Unidos Sidney Kimmel Medical College - Estados Unidos |
| 5 | Brown, Christian A. | Hombre |
Thomas Jefferson Univ - Estados Unidos
Thomas Jefferson University - Estados Unidos Sidney Kimmel Medical College - Estados Unidos |
| 6 | Watt, Stephen A. | Hombre |
Univ Dundee - Reino Unido
University of Dundee - Reino Unido University of Dundee School of Medicine - Reino Unido |
| 7 | Wright, Sheila | Mujer |
Univ Dundee - Reino Unido
University of Dundee - Reino Unido University of Dundee School of Medicine - Reino Unido |
| 8 | Warkala, Michael | Hombre |
Thomas Jefferson Univ - Estados Unidos
Thomas Jefferson University - Estados Unidos Sidney Kimmel Medical College - Estados Unidos |
| 9 | Guttmann-Gruber, Christina | Mujer |
Paracelsus Med Univ - Austria
Paracelsus Medizinische Privatuniversitat - Austria |
| 10 | Piñón Hofbauer, Josefina | Mujer |
Paracelsus Med Univ - Austria
Paracelsus Medizinische Privatuniversitat - Austria |
| 11 | FUENTES-SAN ROMAN, IGNACIO | Mujer |
Fdn DEBRA Chile - Chile
Universidad del Desarrollo - Chile Fundación DEBRA Chile - Chile Clínica Alemana - Chile |
| 12 | YUBERO-GONCALVES, MARIA JOAO | Hombre |
Thomas Jefferson Univ - Estados Unidos
Thomas Jefferson University - Estados Unidos |
| 13 | Rashidghamat, Elham | Mujer |
Kings Coll London - Reino Unido
King's College London - Reino Unido |
| 14 | Has, C. | Mujer |
Univ Freiburg - Alemania
Universität Freiburg im Breisgau - Alemania Universitätsklinikum Freiburg - Alemania |
| 15 | Salas-Alanis, Julio C. | Hombre |
Inst Dearmatol Jalisco - México
Instituto Dearmatologico de Jalisco - México |
| 16 | PALISSON-ETCHARREN, FRANCIS | Hombre |
Fdn DEBRA Chile - Chile
Universidad del Desarrollo - Chile Fundación DEBRA Chile - Chile Clínica Alemana - Chile |
| 17 | Hovnanian, Alain | Hombre |
INSERM UMR 1163 - Francia
Imagine Inst - Francia INSERM - Francia Imagine Institute - Francia l'Institut des Maladies Génétiques Imagine - Francia |
| 18 | McGrath, John A. | Hombre |
Kings Coll London - Reino Unido
King's College London - Reino Unido |
| 19 | Mellerio, J. E. | Mujer |
Kings Coll London - Reino Unido
King's College London - Reino Unido |
| 20 | Bauer, Johann | Hombre |
Paracelsus Med Univ - Austria
Paracelsus Medizinische Privatuniversitat - Austria |
| 21 | South, Andrew P. | Hombre |
Thomas Jefferson Univ - Estados Unidos
Thomas Jefferson University - Estados Unidos Sidney Kimmel Medical College - Estados Unidos |
| Fuente |
|---|
| National Cancer Institute |
| Orionin Tutkimussäätiö |
| Defense Health Agency J9, Research and Development Directorate, through the Congressionally Directed Medical Research Program |
| Office of the Assistant Secretary of Defense for Health Affairs |
| DEBRA International |
| NCI |
| Orion Research Foundation |
| DEBRA International - DEBRA UK |
| Finnish Society of Dermatology |
| Sigrid Juselius Foundation |
| Sigrid Juseliuksen Saatio |
| Congressionally Directed Medical Research Programs |
| DEBRA UK |
| Sigrid Juséliuksen Säätiö |
| Office of the |
| Defense Health Agency J9, Research and Development Directorate |
| Assistant Secretary of Defense for Health Affairs |
| Sidney Kimmel Comprehensive Cancer Center |
| Office of the Assistant Secretary for Health |
| Orionin Tutkimussäätiö |
| Dystrophic Epidermolysis Bullosa Research Association |
| Agradecimiento |
|---|
| This work was supported by DEBRA International-funded by DEBRA UK (grants to A.P. South, and to A.P. South, J.W. Bauer, and J.E. Mellerio) and the Office of the Assistant Secretary of Defense for Health Affairs and the Defense Health Agency J9, Research and Development Directorate, through the Congressionally Directed Medical Research Program under Award No. W81XWH-18-1-0382 (to A.P. South). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. M. Farshchian is supported by the Sigrid Juselius Foundation, Orion Research Foundation, and the Finnish Society of Dermatology. We would like to thank all the patients who contributed to this study, Evan Greenawalt for technical assistance and the Flow Cytometry Shared Resource at the Sidney Kimmel Cancer Center, supported by the NCI, grant 5P30CA056036-17. |
| This work was supported by DEBRA International—funded by DEBRA UK (grants to A.P. South, and to A.P. South, J.W. Bauer, and J.E. Mellerio) and the Office of the Assistant Secretary of Defense for Health Affairs and the Defense Health Agency J9, Research and Development Directorate, through the Congressionally Directed Medical Research Program under Award No. W81XWH-18-1-0382 (to A.P. South). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the |
